Smoking and mental health - NCSCT

More documents

Recommendations

Info

Smoking and mental health 20 Guillem K, Vouillac C, Azar MR, et al. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. European Journal of Neuroscience 2006;24:3532–40. 21 Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM. Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 2007;52:1415–25. 22 Caggiula AR, Donny EC, Chaudhri N, et al.. Importance of nonpharmacological factors in nicotine self-administration. Physiology and Behavior 2002;77:683–7. 23 Caggiula AR, Donny EC, White AR, et al. Cue dependency of nicotine self-administration and smoking. Pharmacology, Biochemistry and Behavior 2001;70:515–30. 24 Chaudhri N, Caggiula AR, Donny EC, et al. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 2006;184:353–66. 25 Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry and Behavior 2000;67:71–81. 26 Brauer LH, Behm FM, Lane JD, et al. Individual differences in smoking reward from denicotinized cigarettes. Nicotine and Tobacco Research 2001;3:101–9. 27 Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006;184:274–85. 28 Caggiula AR, Donny EC, Palmatier MI, Liu X, Chaudhri N, Sved AF. The role of nicotine in smoking: a dual-reinforcement model. Nebraska Symposium on Motivation 2009;55:91–109. 29 Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 1997;4:231–44. 30 Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998;18:135–74. 31 Amitai N, Markou A. Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment. Pharmacology, Biochemistry and Behavior 2009;93:248–57. 32 Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport 2002;13:1097–106. 33 Watkins SS, Koob GF, Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine and Tobacco Research 2000;2:19–37. 34 Dursun SM, Kutcher S. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Medical Hypotheses 1999;52:101–9. 35 Mihailescu S, Drucker-Colin R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Archives of Medical Research 2000;31:131–44. 36 Ferguson SM, Brodkin JD, Lloyd GK, Menzaghi F. Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharmacology 2000;152:295–303. 37 Tizabi Y, Overstreet DH, Rezvani AH, et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 1999;142:193–9. 38 Balfour DJ, Ridley DL. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacology, Biochemistry and Behavior 2000;66:79–85. 39 Kapur S, Mann JJ. Role of the dopaminergic system in depression. Biological Psychiatry 1992;32(1):1–17. 54 © Royal College of Physicians 2013
Neurobiological and behavioural mechanisms linking smoking and mental disorders 3 40 Porcu P, Sogliano C, Cinus M, et al. Nicotine-induced changes in cerebrocortical neuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacology, Biochemistry and Behavior 2003;74:683–90. 41 Rudehill A, Franco-Cereceda A, Hemsen A, et al. Cigarette smoke-induced elevation of plasma neuropeptide Y levels in man. Clinical Physiology 1989;9:243–8. 42 Hahn B, Sharples CG, Wonnacott S, Shoaib M, Stolerman IP. Attentional effects of nicotinic agonists in rats. Neuropharmacology 2003;44:1054–67. 43 Picciotto MR, Caldarone BJ, King SL, Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 2000;22:451–65. 44 Yamazaki Y, Hamaue N, Sumikawa K. Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction. Brain Research 2002;946(1):148–52. 45 Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology 2004;174:54–64. 46 Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 1998;155:1490–501. 47 Chassin L, Presson C, Seo DC, et al. Multiple trajectories of cigarette smoking and the intergenerational transmission of smoking: a multigenerational, longitudinal study of a Midwestern community sample. Health Psychology 2008;27:819–28. 48 Mayhew KP, Flay BR, Mott JA. Stages in the development of adolescent smoking. Drug and Alcohol Dependence 2000;59(suppl 1):S61–81. 49 Kendler KS, Neale MC, MacLean CJ, et al. Smoking and major depression. A causal analysis. Archives of General Psychiatry 1993;50:36–43. 50 Korhonen T, Broms U, Varjonen J, et al. Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins. Psychological Medicine 2007;37:705–15. 51 Lyons M, Hitsman B, Xian H, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine and Tobacco Research 2008;10:97–108. 52 Edwards AC, Maes HH, Pedersen NL, Kendler KS. A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence. Psychological Medicine 2011;41:395–405. 53 Lajtha A, Sershen H. Nicotine: alcohol reward interactions. Neurochemical Research 2010;35:1248–58. 54 Andreasen JT, Redrobe JP. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behavioral Pharmacology 2009;20:286–95. 55 Suemaru K, Yasuda K, Cui R, et al. Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiology and Behavior 2006;88:545–9. 56 Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine]. Pharmacology, Biochemistry and Behavior 2004;78:165–9. 57 Djuric VJ, Dunn E, Overstreet DH, Dragomir A, Steiner M. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiology and Behavior 1999;67:533–7. 58 Tizabi Y, Getachew B, Rezvani AH, Hauser SR, Overstreet DH. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009;33:398–402. © Royal College of Physicians 2013 55
Page 1 and 2:
PDF not for circulation Smoking and
Page 3 and 4:
Contents Members of the Tobacco Adv
Page 5 and 6:
Contents 4.4.3 Attention deficit hy
Page 7 and 8:
Contents 6.4.3 Staff knowledge 122
Page 9 and 10:
Contents 10.5 Tobacco policy and me
Page 11 and 12:
Contributors Anthony Aclet - Specia
Page 13 and 14:
Contributors Jill Williams - Associ
Page 15 and 16:
1 Mental disorders 1.1 What is a me
Page 17 and 18: Mental disorders 1 1.3 Common menta
Page 19 and 20: Mental disorders 1 1.4.4 Somatisati
Page 21 and 22: Mental disorders 1 In addition to s
Page 23 and 24: Mental disorders 1 not diagnosed un
Page 25 and 26: Mental disorders 1 Similar to many
Page 27 and 28: Mental disorders 1 12 Chang CK, Hay
Page 29 and 30: Mental disorders 1 52 Young S, Toon
Page 31 and 32: Smoking among people with mental di
Page 53 and 54: Neurobiological and behavioural mec
Page 67: Neurobiological and behavioural mec
Page 77 and 78: Epidemiology of the association bet
Page 99 and 100: Smoking cessation interventions for
Page 119 and 120:
Smoking cessation interventions for
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
6 Population strategies to prevent
Page 127 and 128:
Population strategies to prevent sm
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Smoking and mental disorders: speci
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
The economic cost of smoking in peo
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Ethical and legal aspects 9 pose co
Page 199 and 200:
Ethical and legal aspects 9 less an
Page 201 and 202:
Ethical and legal aspects 9 patient
Page 203 and 204:
10 Summary and conclusions 10.1 Smo
Page 205 and 206:
Summary and conclusions 10 10.4 Smo
Page 207 and 208:
Summary and conclusions 10 although
Page 209 and 210:
11 Key conclusions and recommendati
Page 211 and 212:
Key conclusions and recommendations
Page 213 and 214:
Page 215:
show all

Smoking and mental health - NCSCT

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?